SteadyMD
White-label clinician network and virtual care operations

SteadyMD, a DocGo company, supplies a 50-state clinician network, clinical operations, and technology for brands running their own virtual care programs.
Best for
- Digital health brands and labs that need licensed clinicians in all 50 states under their own brand
- Companies adding clinician review to AI or asynchronous care programs
Not ideal for
- Health systems that only need a video visit tool for their own staff
- Buyers wanting a published per-visit price before talking to sales

Bottom line
SteadyMD is a solid option for brands that need a nationwide clinician workforce and operational support behind their own virtual care program. It fits best when the scope, clinical protocols, and responsibilities are written down from the start.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
SteadyMD serves companies that want to offer clinician-led virtual care under their own brand without building a medical group. Wheel is a direct alternative for white-label virtual care with a 50-state clinician network. Video software without clinicians covers only a small part of this job.
DocGo acquired SteadyMD in October 2025, and SteadyMD continues to operate as a DocGo company. Buyers should compare an equivalent program with Wheel, including clinician mix, response times, licensing, and who carries regulatory responsibility.
- Outcomes and workflow value (7.3): Years of partner programs and a large patient base support operational value, though outcome data is partner-specific.
- Product and service depth (7.8): Clinician staffing, licensing, protocols, APIs, and a digital clinic cover the infrastructure job.
- Ease of implementation (7.3): SteadyMD says programs can launch in as little as 30 days, with integration options from embedded to standalone.
- Pricing clarity (5.6): No public pricing is listed; costs depend on visit volume and services.
Clinician Network and Operations
SteadyMD supplies physicians, nurse practitioners, and genetic counselors licensed across all 50 states. It handles recruiting, scheduling, clinical protocols, prescriptions, labs, and state legal requirements. Its acquisition of BlocHealth added licensing and credentialing tools.
At the DocGo acquisition, SteadyMD was described as having more than 600 clinicians and serving over 3 million patients. In January 2026 it announced plans to grow clinical staff by up to 50% to meet demand for branded GLP-1 weight loss programs. Rapid hiring is a reason to ask about clinician onboarding and quality review.
Technology and AI Review
Partners can embed SteadyMD in their own systems through APIs or use the SteadyMD Digital Clinic. For AI programs, the company offers a clinician-in-the-loop model where a partner's chatbot handles the conversation and SteadyMD clinicians review and approve recommendations, with escalation to video or asynchronous visits.
This model suits companies building AI front ends that still need licensed decisions. Partners should agree on liability, documentation standards, and escalation timing before launch.
What Changes Under DocGo
DocGo says the combination links SteadyMD's virtual care with its mobile health and in-home services, so a virtual visit can lead to a home test and a follow-up consult. That could help partners that need both virtual and in-person steps.
Ownership changes can bring new contract terms and priorities. Existing and prospective partners should confirm account management, pricing stability, and whether DocGo services are bundled or optional.
Product and service details: steadymd.com, steadymd.com.
Company scale
Similarweb's September 2026 profile estimates SteadyMD annual revenue at $25 million to $50 million. DocGo expected SteadyMD to generate about $25 million in 2025. Scale source
What People Say
What people like
"SteadyMD has been an outstanding partner. Their clinical leadership team is great and collaborative."
"Having licensed clinicians in every state ready behind our app saved us from building a medical group."
What people don't like
"After the acquisition we needed new conversations about who our account team was and which terms would carry over."
Where customer reviews couldn't be found, our analysts attempted to give a voice to buyer sentiment, drawing on real information from review sites, forums and product documentation.
Based on: Product or service details, Product or service details.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| SteadyMD | 7.2 | 7.3 |
| Wheel | 7.3 | 7.2 |
| OpenLoop | 7.6 | 7.1 |
Pricing
| Item | Detail |
|---|---|
| Commercial model | Partner agreements priced by program scope and volume; no public rates. |
| Launch | SteadyMD says programs can go live in as little as 30 days. |
| Compare equivalent scope | Include clinician types, state coverage, visit modalities, response times, labs, prescriptions, and integration work. |
Recent news
- January 2026: SteadyMD announced plans to grow its clinical staff by up to 50% to meet demand for branded GLP-1 weight loss care.
- October 2025: DocGo acquired SteadyMD, adding a 50-state virtual care network with more than 600 clinicians.
Methodology
We reviewed product documentation, published service evidence, pricing, and customer accounts available on November 8, 2026. Scores are editorial assessments on a ten-point scale. The overall score weights outcomes and workflow value at 35%, product at 30%, implementation at 20%, and pricing clarity at 15%. Company-website testimonials are vendor-selected accounts.
Existing peer scores are carried from the linked HIR reviews.
Sources
- Healthcare Industry Reviews analysis of the product, service, and pricing sources below, conducted November 2026.
- steadymd.com ·
- steadymd.com · digital health companies
- similarweb.com · company/steadymd.com
- docgo.com · press/docgo acquires virtual care platform steadymd expands telehealth services across all 50 states
- steadymd.com · technology
- steadymd.com · about us
- docgo.com · press/docgo s steadymd announces immediate expansion of clinical workforce to meet rising demand for branded glp 1 weight loss care